BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32265995)

  • 1. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
    Xia C; He Z; Cai Y
    Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
    Zhang L; Zhou J; Qin X; Huang H; Nie C
    Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function.
    Feng X; Zhou J; Li J; Hou X; Li L; Chen Y; Fu S; Zhou L; Li C; Lei Y
    Cell Death Dis; 2018 Nov; 9(11):1117. PubMed ID: 30389907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer.
    Cheng H; Long J; Su J; Chu J; Wang M; Li Q
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3179-3194. PubMed ID: 37906274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin.
    Xia C; Yang F; He Z; Cai Y
    Biomed Pharmacother; 2020 Mar; 123():109762. PubMed ID: 31864213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
    Hu T; Fei Z; Wei N
    Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression.
    Luo CL; Liu YQ; Wang P; Song CH; Wang KJ; Dai LP; Zhang JY; Ye H
    Biomed Pharmacother; 2016 Aug; 82():595-605. PubMed ID: 27470402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo.
    Zhang H; Xie B; Zhang Z; Sheng X; Zhang S
    Drug Des Devel Ther; 2019; 13():119-127. PubMed ID: 30587932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
    Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
    World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway.
    Guo LH; Cao Y; Zhuang RT; Han Y; Li J
    Int J Mol Med; 2019 Feb; 43(2):830-838. PubMed ID: 30535481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
    Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
    Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway.
    Li B; Wang F; Liu N; Shen W; Huang T
    Biochem Biophys Res Commun; 2017 Sep; 491(1):98-103. PubMed ID: 28709870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
    Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
    Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV Induces Apoptosis, G
    Su CM; Wang HC; Hsu FT; Lu CH; Lai CK; Chung JG; Kuo YC
    In Vivo; 2020; 34(2):631-638. PubMed ID: 32111763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
    Ye Q; Su L; Chen D; Zheng W; Liu Y
    Cell Physiol Biochem; 2017; 43(4):1617-1626. PubMed ID: 29041002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
    Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells.
    Xiong LL; Du RL; Chen JJ; Jiang Y; Xue LL; Niu RZ; Chen L; Liu J; Wang TH
    Biomed Res Int; 2020; 2020():9786428. PubMed ID: 33102601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.